Vista Therapeutics raises more funds
January 2010
“Santa Fe-based Vista Therapeutics Inc. is about to close on $1.5 million in new venture funding. The company, which created a nanotechnology-based medical device to continuously monitor body fluids in trauma patients, closed on $200,000 from the New Mexico Angels and other individual investors on Dec. 31. Another $1.3 million will come from institutional investors, with a final close expected in early February, said Vista CEO Spencer Farr, Ph.D….Vista’s device provides real-time snapshots of protein changes in trauma patients, allowing medical personnel to continuously assess an individual’s condition and measure responses to medication in trauma situations. That can significantly improve treatment, because today doctors must send blood, urine or other body fluid samples to labs for analysis….The device, called a NanoBioSensor, relies on electrically charged nanowires that, when lined with certain antigens, attract target proteins in body fluids….Vista plans to raise another $5 to $8 million in venture capital in late spring to launch a much more extensive marketing campaign, Farr said.” New Mexico Business Weekly
